The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world.
 
Seng Wee Cheo
No Relationships to Disclose
 
Pei-Yi Ong
No Relationships to Disclose
 
Samuel Guan Wei Ow
No Relationships to Disclose
 
Gloria Hui Jia Chan
No Relationships to Disclose
 
David Shao Peng Tan
Honoraria - AstraZeneca; Bayer; Genmab/Seagen; Merck Serono; Merck Sharp & Dohme; novartis; roche; Tessa Therapeutics
Consulting or Advisory Role - AstraZeneca; Bayer; Etc; Genmab; Merck Sharp & Dohme; Roche; Tessa Therapeutics
 
Yi Wan Lim
No Relationships to Disclose
 
Hwai L. Kong
No Relationships to Disclose
 
Andrea Wong
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly/DKSH; Pfizer
Research Funding - Otsuka Pharmaceuticals
 
Siew Eng Lim
No Relationships to Disclose
 
Robert John Walsh
No Relationships to Disclose
 
Alvin S.C. Wong
No Relationships to Disclose
 
Jeffrey Low
No Relationships to Disclose
 
Natalie Yl Ngoi
No Relationships to Disclose
 
Joline Si Jing Lim
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; DKSH; Everest Medicine; MSD; Novartis; Pfizer
Research Funding - CTI BioPharma Corp (Inst)
Travel, Accommodations, Expenses - MSD
 
Soo-Chin Lee
Consulting or Advisory Role - ACT genomics; Daiichi Sankyo; DKSH; Gilead Sciences; Lilly O.; MSD; Novartis; Pfizer; R & D Systems Inc.
Research Funding - ACT Genomics; Bayer; Eisai; Karyopharm Therapeutics; Pfizer; Taiho Oncology
Travel, Accommodations, Expenses - Amgen; Pfizer; Roche